SLE
Showing 1 - 25 of 1,077
SLE Patients Treated With Anifrolumab in Early Access Programs
Not yet recruiting
- Systemic Lupus Erythematosus
- None (Observational study)
- (no location specified)
Sep 13, 2023
Systemic Lupus Erythematosus Trial (Placebo, Ianalumab)
Not yet recruiting
- Systemic Lupus Erythematosus
- Placebo
- Ianalumab
- (no location specified)
Nov 15, 2023
Gonadotropin-releasing Hormone Agonist in Ovarian Preservation
Recruiting
- Systemic Lupus Erythematosus (Sle)
- Primary Ovarian Insufficiency (Poi)
-
Bethesda, MarylandNational Institute of Arthritis and Musculoskeletal and Skin Dis
Feb 2, 2023
Among Juvenile, Adult, and Late-onset Systemic Lupus
Not yet recruiting
- Systemic Lupus Erythematosus (SLE)
- clinical and serological differences among juvenile, adult, and late-onset systemic lupus erythematosus in a cohort of SLE patients
- (no location specified)
Feb 10, 2023
Systemic Lupus Erythematosus (SLE) Trial in Shanghai (anti-CD19 CAR NK cells (KN5501))
Recruiting
- Systemic Lupus Erythematosus (SLE)
- anti-CD19 CAR NK cells (KN5501)
-
Shanghai, ChinaChanghai Hospital
Aug 25, 2023
Lupus Erythematosus, Systemic Trial in Berlin (CC-97540, Fludarabine, Cyclophosphamide)
Not yet recruiting
- Lupus Erythematosus, Systemic
- CC-97540
- +2 more
-
Berlin, GermanyLocal Institution - 0025
May 22, 2023
Type I IFN Level and Disease Activity in SLE Patients
Not yet recruiting
- Elevated Level of IFN Type I in SLE Patients
- study of IFNGS expression biomarkers
- (no location specified)
Jun 30, 2022
Systemic Lupus Erythematosus (SLE) Trial (Descartes-08)
Not yet recruiting
- Systemic Lupus Erythematosus (SLE)
- (no location specified)
Sep 8, 2023
Systemic Lupus Erythematosus Trial in Durham (SLE@Duke)
Completed
- Systemic Lupus Erythematosus
- SLE@Duke
-
Durham, North CarolinaDuke University Medical Center
Aug 12, 2022
Lupus Erythematosus, Systemic, Lupus Erythematosus, Cutaneous Trial (Placebo, PF-06823859)
Not yet recruiting
- Lupus Erythematosus, Systemic
- Lupus Erythematosus, Cutaneous
- Placebo
- PF-06823859
- (no location specified)
May 18, 2023
Among SLE Patients Receiving Anifrolumab in Routine Clinical
Not yet recruiting
- Systemic Lupus Erythematosus
- None (Observational study)
- (no location specified)
Nov 24, 2022
Data Obtained With LuGENEĀ® Multiparameter Transcriptomics Blood
Not yet recruiting
- Lupus Erythematosus, Systemic
- Decision Support Test
- (no location specified)
Apr 25, 2023
CAR-T Cell Therapy Trial in Shanghai (GC012F injection)
Recruiting
- CAR-T Cell Therapy
- GC012F injection
-
Shanghai, Shanghai, ChinaDepartment of Rheumatology, Ren Ji Hospital South Campus, School
May 5, 2023
Relapsed/Refractory, Systemic Lupus Erythematosus (SLE) Trial in Zhongshan (BCMA-CD19 cCAR T cells)
Recruiting
- Relapsed/Refractory, Systemic Lupus Erythematosus (SLE)
- BCMA-CD19 cCAR T cells
-
Zhongshan, Guangdong, ChinaZhongshan People's Hospital
Jul 23, 2022
Steroid-induced Diabetes Mellitus in Systemic Lupus
Not yet recruiting
- System; Lupus Erythematosus
- (no location specified)
Jul 24, 2022
APS Secondary to SLE
Recruiting
- Antiphospholipid Syndrome
- Telitacicept
- +5 more
-
Jinan, Shandong, ChinaQilu Hospital
Nov 30, 2022
Osteoporosis and Fragility Fractures Among SLE Patients.
Recruiting
- Lupus Erythematosus, Systemic
- DXA
- +2 more
-
Verona, ItalyAOUI Verona - UOC Reumatologia
Oct 18, 2022
Infant, Premature, Diseases, Respiratory Tract Diseases, Cerebral Blood Flow Trial in Cairo (High Frequency Oscillatory
Not yet recruiting
- Infant, Premature, Diseases
- +2 more
- High Frequency Oscillatory Ventilation with Volume Guarantee (SLE6000;SLE)
- High Frequency Oscillatory Ventilation (SLE6000;SLE)
-
Cairo, Abbasia, EgyptNeonatal Intensive Care Units (NICUs), Ain Shams University
Oct 20, 2022
Systemic Lupus Erythematosus Trial (ianalumab, )
Not yet recruiting
- Systemic Lupus Erythematosus
- ianalumab
- placebo
- (no location specified)
Nov 21, 2022
Autotaxin as Abiomarker in Systemic Lupus Erythematosus Patients
Not yet recruiting
- SLE (Systemic Lupus)
- (no location specified)
Oct 1, 2023
SLE Patients Admitted to Critical Care Unit
Not yet recruiting
- Systemic Lupus Erythematosus
- (no location specified)
Jun 13, 2022
Systemic Lupus Erythematosus, Contraception Trial in Chicago (HOP-STEP (Healthy Outcomes in Pregnancy with SLE Through Education
Not yet recruiting
- Systemic Lupus Erythematosus
- Contraception
- HOP-STEP (Healthy Outcomes in Pregnancy with SLE Through Education of Providers) Intervention
- Routine Care
-
Chicago, IllinoisUniversity of Chicago Medical Center
Apr 17, 2023
Systemic Lupus Erythematosus Trial (Ianalumab, Placebo)
Not yet recruiting
- Systemic Lupus Erythematosus
- Ianalumab
- Placebo
- (no location specified)
Dec 5, 2022
Systemic Lupus Erythematosus Trial in Nantong, Shanghai (Anifrolumab)
Completed
- Systemic Lupus Erythematosus
- Anifrolumab
-
Nantong, China
- +2 more
Aug 17, 2022
Lupus Erythematosus, Systemic, Purpura, Thrombocytopenic, Idiopathic, Glucocorticoids Trial in Fuzhou (rapid GCs taper)
Enrolling by invitation
- Lupus Erythematosus, Systemic
- +3 more
- rapid GCs taper
-
Fuzhou, Fujian, ChinaFujian Medical University Union Hospital
Aug 16, 2022